A ready-made EL7 screen
Growth at a fair price
Forward P/E up to 25 with ROIC above 10% and 5-year EPS estimates
Growth at a reasonable price, Peter Lynch style: a forward P/E between 0 and 25, return on invested capital above 10%, and a consensus EPS estimate of at least $12 five years out. Five-year estimates exist for about a third of the market, so a short list reflects coverage, not strictness.
79 matching companies
What this screen asks for
Financial ratios
- Forward P/Ebetween 0 and 25
- ROIC10% or more
- Forecast EPS (5yr)12 or more
Matches
| Symbol | Company | Price | Change | EL7 Factor | Market cap |
|---|---|---|---|---|---|
| NVDANVIDIA Corporation | NVIDIA Corporation | 230.36 | +0.84% | 94 | 5.6T |
| GOOGLAlphabet Inc. | Alphabet Inc. | 338.46 | −1.17% | 77 | 4.1T |
| AVGOBroadcom Inc. | Broadcom Inc. | 357.90 | +0.21% | 91 | 1.7T |
| METAMeta Platforms, Inc. | Meta Platforms, Inc. | 616.77 | +1.00% | 70 | 1.6T |
| JNJJohnson & Johnson | Johnson & Johnson | 275.23 | −1.15% | 80 | 663.3B |
| ABBVAbbVie Inc. | AbbVie Inc. | 256.34 | −1.49% | 88 | 452.9B |
| CVXChevron Corporation | Chevron Corporation | 208.53 | −1.32% | 94 | 415.3B |
| UNHUnitedHealth Group Incorporated | UnitedHealth Group Incorporated | 397.14 | −0.95% | 86 | 360.7B |
| HDThe Home Depot, Inc. | The Home Depot, Inc. | 321.05 | +0.94% | 44 | 320.1B |
| NVSNovartis AG | Novartis AG | 159.99 | −1.90% | 83 | 304.1B |
Showing 10 of 79
69 more companies match the same criteria and are available to subscribers.